Prostate Cancer

Covid Cuts A Lethal Path Through San Quentin’s Death Row

The old men live in cramped spaces and breathe the same ventilated air. Many are frail, laboring with heart disease, liver and prostate cancer, tuberculosis, dementia. And now, with the coronavirus advancing through their ranks, they are falling one...
Related topics: Cardiovascular Disease, Liver Disease, Liver Cancer, Cancer, Oncology, Tuberculosis, Dementia

Read More →

Protein Linked To Cancer Acts As A Viscous Glue In Cell Division

An over-abundance of the protein PRC1, which is essential to cell division, is a telltale sign in many cancer types, including prostate, ovarian, and breast cancer. New research, published online today in Developmental Cell, shows that PRC1 acts as...
Related topics: Proteins, Breast Cancer, Cancer, Ovarian Cancer, Oncology, Medical Research

Read More →

New Focus On Adt In Prostate Cancer Guideline

(MedPage Today) -- For the first time in its long and storied history, hormonal therapy for advanced prostate cancer has received broad and detailed attention in a clinical practice guideline. The new American Urological Association (AUA)...
Related topics: Cancer, Oncology, Hormones

Read More →

News Digest – Targeted Drug Approval, Microbubble ‘warheads’ And Prostate Cancer Treatment

With news about the coronavirus pandemic developing daily, we want to make sure everyone affected by cancer gets the information they need during this time.  We’re pulling together the latest government and NHS health updates from across the UK...
Related topics: Cancer, Oncology

Read More →

Coronavirus Reports: “as A Black Man With Advanced Prostate Cancer, Who Wouldn’t Be Worried?”

Earlier this month, Public Health England published a long-awaited report on how factors like age, ethnicity and sex are linked to a person’s risk of COVID-19. The report confirmed what many news headlines had already implied – that COVID-19...
Related topics: Cancer, Oncology

Read More →

Ctc Count Can Predict Outcome In Prostate Cancer

(MedPage Today) -- Baseline circulating tumor cell (CTC) count was found to be significantly predictive of clinical outcome in a phase III trial of metastatic castration-sensitive prostate cancer (mCSPC) presented at the 2020 American Society of...
Related topics: American Cancer Society, Cancer, Oncology, Clinical Trials

Read More →

Consider Genetic Testing In All Metastatic Prostate Cancers

(MedPage Today) -- All men with metastatic prostate cancer should consider testing for germline mutations, as should men with a family history of cancer suggesting hereditary cancer predisposition, an international consensus panel recommended...
Related topics: Genetics, Cancer, Oncology

Read More →

Prostate Cancer Trial Participants Overwhelmingly White

TUESDAY, June 9, 2020 -- Prostate cancer clinical trial participants are overwhelmingly white, according to a study published online June 5 in Cancer Epidemiology, Biomarkers & Prevention. Emily M. Rencsok, from the Harvard T.H. Chan School of...
Related topics: Cancer, Oncology, Clinical Trials, Medical Research, Harvard University

Read More →

News Digest – Prostate Cancer, Covid-19 Trials, Breast Cancer Genes And Street Lamps?

With news about the coronavirus pandemic developing daily, we want to make sure everyone affected by cancer gets the information they need during this time.  We’re pulling together the latest government and NHS health updates from across the UK...
Related topics: Breast Cancer, Cancer, Oncology, Genetics

Read More →

Some Types Of Prostate Cancer May Not Be As Aggressive As Originally Thought

Researchers at the UCLA Jonsson Comprehensive Cancer Center analyzed gene-expression patterns in the most aggressive prostate cancer grade group — known as Gleason grade group 5 — and found that this grade of cancer can actually be...
Related topics: Cancer, Oncology, Medical Research, Genetics

Read More →

Postdiagnosis Obesity, Weight Gain Tied To Worse Prostate Cancer Outcomes

(MedPage Today) -- Study Authors: Alyssa N. Troeschel, Terryl J. Hartman, et al.; Catherine H. Marshall, Corinne E. Joshu Target Audience and Goal Statement: Oncologists, urologists The goal of this study was to determine the association between...
Related topics: Obesity, Cancer, Oncology, Medical Research

Read More →

Oral Adt Slashes Heart Risk In Advanced Prostate Cancer

]]>(MedPage Today) -- Androgen-deprivation therapy (ADT) with an oral gonadotropin-releasing hormone (GnRH) antagonist rapidly suppressed testosterone and cut the incidence of serious heart events compared to an injectable form of ADT, a phase III...
Related topics: Oral Cancer, Cancer, Oncology, Hormones

Read More →

Studies Make Case For Hormonal Therapy In Nmcrpc

]]>(MedPage Today) -- Men with nonmetastatic castration-resistant prostate cancer (nmCRPC) lived significantly longer if they received an androgen signaling inhibitor (ASI) in addition to conventional androgen deprivation therapy (ADT), three...
Related topics: Hormones, Cancer, Oncology

Read More →

Prostate Cancer Drug Could Be 'game Changing,' Researchers Say

FRIDAY, May 29, 2020 -- For men with advanced prostate cancer, a new hormone therapy pill works better than standard injections -- and carries a much lower risk of heart attack or stroke, a clinical trial has found. The drug, called relugolix, is...
Related topics: Cancer, Oncology, Medical Research, Hormones, Stroke, Clinical Trials

Read More →

New Drugs Make Headway Against Lung, Prostate, Colon Cancers

Doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear
Related topics: Lung Cancer, Colon Cancer, Cancer, Oncology

Read More →

Sugars Could Be The Key To An Earlier, More Accurate Test For Prostate Cancer

A new type of test that uses complex sugars to detect prostate cancer earlier and with greater accuracy.
Related topics: Cancer, Oncology

Read More →

Rt Plus Adt Tops Brachytherapy Boost For Prostate Cancer

]]>(MedPage Today) -- Men with localized prostate cancer lived longer when treated with external beam radiation therapy (EBRT) plus androgen deprivation therapy (ADT) but not EBRT with a brachytherapy boost (BT), a meta-analysis showed. The...
Related topics: Cancer, Oncology

Read More →

Advanced Prostate Cancer Cases Continue To Rise In U.s.

]]>(MedPage Today) -- Coinciding with declines in prostate-specific antigen (PSA) screening over the last decade, the incidence of intermediate- and high-risk prostate cancer has continued to increase across the U.S. in men 50 and older, a...
Related topics: Cancer, Oncology

Read More →

Astrazeneca/merck's Lynparza Get Fda Nod For Prostate Cancer

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AstraZeneca PLC (AZN): Free Stock Analysis Report Pfizer Inc. (PFE): Free Stock...
Related topics: Astrazeneca, Merck & Co, Food And Drug Administration, Cancer, Oncology, Medical Research, Pfizer

Read More →

Local-stage Prostate Cancer Incidence Rates Continue To Drop

WEDNESDAY, May 20, 2020 -- Prostate cancer incidence rates decreased from 2005 to 2016 for local-stage disease among men aged ≥50 years but increased for regional- and distant-stage disease, according to a study published online May 20 in the...
Related topics: Cancer, Oncology, Medical Research

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.